281 related articles for article (PubMed ID: 28941178)
1. Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice.
Fan T; Rong Z; Dong J; Li J; Wang K; Wang X; Li H; Chen J; Wang F; Wang J; Wang A
Cancer Med; 2017 Oct; 6(10):2370-2384. PubMed ID: 28941178
[TBL] [Abstract][Full Text] [Related]
2. Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification.
Beyoğlu D; Imbeaud S; Maurhofer O; Bioulac-Sage P; Zucman-Rossi J; Dufour JF; Idle JR
Hepatology; 2013 Jul; 58(1):229-38. PubMed ID: 23463346
[TBL] [Abstract][Full Text] [Related]
3. Role of the Mitochondrial Citrate-malate Shuttle in
Lei C; Chen J; Li H; Fan T; Zheng X; Wang H; Zhang N; Liu Y; Luo X; Wang J; Wang A
Metabolites; 2020 May; 10(5):. PubMed ID: 32414018
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic Analysis of Liver Tissues for Characterization of Hepatocellular Carcinoma.
Ferrarini A; Di Poto C; He S; Tu C; Varghese RS; Kara Balla A; Jayatilake M; Li Z; Ghaffari K; Fan Z; Sherif ZA; Kumar D; Kroemer A; Tadesse MG; Ressom HW
J Proteome Res; 2019 Aug; 18(8):3067-3076. PubMed ID: 31188000
[TBL] [Abstract][Full Text] [Related]
5. Tracking cellular metabolomics in lipoapoptosis- and steatosis-developing liver cells.
Noguchi Y; Young JD; Aleman JO; Hansen ME; Kelleher JK; Stephanopoulos G
Mol Biosyst; 2011 May; 7(5):1409-19. PubMed ID: 21327189
[TBL] [Abstract][Full Text] [Related]
6. DNA Damage Response Protein CHK2 Regulates Metabolism in Liver Cancer.
Lulli M; Del Coco L; Mello T; Sukowati C; Madiai S; Gragnani L; Forte P; Fanizzi FP; Mazzocca A; Rombouts K; Galli A; Carloni V
Cancer Res; 2021 Jun; 81(11):2861-2873. PubMed ID: 33762357
[TBL] [Abstract][Full Text] [Related]
7. The aspartate metabolism pathway is differentiable in human hepatocellular carcinoma: transcriptomics and (13) C-isotope based metabolomics.
Darpolor MM; Basu SS; Worth A; Nelson DS; Clarke-Katzenberg RH; Glickson JD; Kaplan DE; Blair IA
NMR Biomed; 2014 Apr; 27(4):381-9. PubMed ID: 24497316
[TBL] [Abstract][Full Text] [Related]
8. Integrative functional genomic analysis unveils the differing dysregulated metabolic processes across hepatocellular carcinoma stages.
Ramesh V; Ganesan K
Gene; 2016 Aug; 588(1):19-29. PubMed ID: 27107678
[TBL] [Abstract][Full Text] [Related]
9. Essential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features.
Kopanja D; Pandey A; Kiefer M; Wang Z; Chandan N; Carr JR; Franks R; Yu DY; Guzman G; Maker A; Raychaudhuri P
J Hepatol; 2015 Aug; 63(2):429-36. PubMed ID: 25828473
[TBL] [Abstract][Full Text] [Related]
10. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
[TBL] [Abstract][Full Text] [Related]
11. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics.
Huang Q; Tan Y; Yin P; Ye G; Gao P; Lu X; Wang H; Xu G
Cancer Res; 2013 Aug; 73(16):4992-5002. PubMed ID: 23824744
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis.
Lu M; Hartmann D; Braren R; Gupta A; Wang B; Wang Y; Mogler C; Cheng Z; Wirth T; Friess H; Kleeff J; Hüser N; Sunami Y
BMC Cancer; 2019 Sep; 19(1):887. PubMed ID: 31488102
[TBL] [Abstract][Full Text] [Related]
13. Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours.
Nwosu ZC; Battello N; Rothley M; Piorońska W; Sitek B; Ebert MP; Hofmann U; Sleeman J; Wölfl S; Meyer C; Megger DA; Dooley S
J Exp Clin Cancer Res; 2018 Sep; 37(1):211. PubMed ID: 30176945
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome and proteome of human hepatocellular carcinoma reveal shared metastatic pathways with significant genes.
Shen H; Zhong F; Zhang Y; Yu H; Liu Y; Qin L; He F; Tang Z; Yang P
Proteomics; 2015 Jun; 15(11):1793-800. PubMed ID: 25652264
[TBL] [Abstract][Full Text] [Related]
15. Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment.
Cassim S; Raymond VA; Dehbidi-Assadzadeh L; Lapierre P; Bilodeau M
Cell Cycle; 2018; 17(7):903-916. PubMed ID: 29633904
[TBL] [Abstract][Full Text] [Related]
16. HBx regulates fatty acid oxidation to promote hepatocellular carcinoma survival during metabolic stress.
Wang MD; Wu H; Huang S; Zhang HL; Qin CJ; Zhao LH; Fu GB; Zhou X; Wang XM; Tang L; Wen W; Yang W; Tang SH; Cao D; Guo LN; Zeng M; Wu MC; Yan HX; Wang HY
Oncotarget; 2016 Feb; 7(6):6711-26. PubMed ID: 26744319
[TBL] [Abstract][Full Text] [Related]
17. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.
Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY
Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277
[TBL] [Abstract][Full Text] [Related]
18. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D
Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis revealed common, unique and systemic signatures in gender-dependent hepatocarcinogenesis.
Li H; Rong Z; Wang H; Zhang N; Pu C; Zhao Y; Zheng X; Lei C; Liu Y; Luo X; Chen J; Wang F; Wang A; Wang J
Biol Sex Differ; 2020 Aug; 11(1):46. PubMed ID: 32792008
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated signaling hubs of liver lipid metabolism reveal hepatocellular carcinoma pathogenesis.
Lee S; Mardinoglu A; Zhang C; Lee D; Nielsen J
Nucleic Acids Res; 2016 Jul; 44(12):5529-39. PubMed ID: 27216817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
